ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	16.37	17.57	22.41	48.82	363.67
Short-Term Investments	28.42	110.19	160.33	217.39	-
Cash & Short-Term Investments	44.79	127.76	182.74	266.21	363.67
Cash Growth	-64.94%	-30.09%	-31.36%	-26.80%	-16.25%
Other Current Assets	5.94	6.6	5.92	4.76	3.35
Total Current Assets	50.73	134.35	188.66	270.97	367.02
Net Property, Plant & Equipment	1.2	2.91	3.59	3.89	0.9
Long-Term Investments	3.49	3.52	35.41	16.7	-
Other Long-Term Assets	3.63	6.99	14.89	14.93	12.27
Total Assets	59.05	147.78	242.55	306.49	380.18
Accounts Payable	4.91	4.65	9.13	9.72	5.39
Accrued Expenses	14.42	13.42	26.87	18.6	9.9
Current Portion of Long-Term Debt	5.22	0.44	-	-	-
Total Current Liabilities	24.55	18.5	36	28.33	15.3
Long-Term Debt	4.53	9.47	9.64	9.39	-
Other Long-Term Liabilities	3.98	6.19	7.2	5.31	1.84
Total Long-Term Liabilities	8.51	15.66	16.84	14.7	1.84
Total Liabilities	33.07	34.16	52.84	43.03	17.13
Common Stock	0.05	0.05	0	0.04	0.04
Additional Paid-in Capital	748.72	734.41	675.68	589.74	564.99
Accumulated Other Comprehensive Income	0.03	0.28	0.26	-0.85	-
Retained Earnings	-722.82	-621.12	-486.27	-325.47	-201.99
Shareholders' Equity	25.98	113.62	189.71	263.46	363.05
Total Liabilities & Equity	59.05	147.78	242.55	306.49	380.18
Total Debt	9.75	9.9	9.64	9.39	0
Net Cash (Debt)	35.04	117.85	173.1	256.82	363.67
Net Cash Growth	-70.27%	-31.91%	-32.60%	-29.38%	-16.25%
Net Cash Per Share	0.65	2.26	4.03	6.31	9.02
Book Value	25.98	113.62	189.71	263.46	363.05
Book Value Per Share	0.48	2.18	4.41	6.47	9.01
Tangible Book Value	25.98	113.62	189.71	263.46	363.05
Tangible Book Value Per Share	0.48	2.18	4.41	6.47	9.01

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q